4 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow Aribio Lab Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above CVI-VZV-001, Shingrix - Vaccine-Preventable Diseases, Herpes Zoster | Phase 1 | Completed | Aribio Lab Co., Ltd. | 35 | 2023-03-15 | 2026-10-28 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine CVI-HBV-002 - Vaccine-Preventable Diseases, Hepatitis B | Phase 1 | Completed | Aribio Lab Co., Ltd. | 30 | 2021-09-17 | 2024-03-25 |
| A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine CVI-HBV-002 - Hepatitis B, Chronic | Phase 1 / Phase 2 | Completed | Aribio Lab Co., Ltd. | 53 | 2014-10-28 | 2023-11-18 |
| A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine CVI-HBV-001, Conventional Hepatitis B vaccine (20 μg) - Healthy | Phase 1 / Phase 2 | Completed | Aribio Lab Co., Ltd. | 75 | 2012-12-07 | 2023-11-18 |
Vaccine-Preventable Diseases (2) · Hepatitis B (1) · Hepatitis B, Chronic (1) · Herpes Zoster (1)
South Korea (3)
Jeonghyeon Choi (1) · Kyu-Sung Rim, M.D., Ph.D. (1) · Seong Gyu Hwang, M.D., Ph.D. (1) · Youngsang Kim (1)